4WEL

Crystal structure of Pseudomonas aeruginosa PBP3 with SMC-3176


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.99 Å
  • R-Value Free: 0.220 
  • R-Value Work: 0.190 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

SAR and Structural Analysis of Siderophore-Conjugated Monocarbam Inhibitors of Pseudomonas aeruginosa PBP3.

Murphy-Benenato, K.E.Dangel, B.Davis, H.E.Durand-Reville, T.F.Ferguson, A.D.Gao, N.Jahic, H.Mueller, J.P.Manyak, E.L.Quiroga, O.Rooney, M.Sha, L.Sylvester, M.Wu, F.Zambrowski, M.Zhao, S.X.

(2015) Acs Med.Chem.Lett. 6: 537-542

  • DOI: 10.1021/acsmedchemlett.5b00026
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • A main challenge in the development of new agents for the treatment of Pseudomonas aeruginosa infections is the identification of chemotypes that efficiently penetrate the cell envelope and are not susceptible to established resistance mechanisms. Si ...

    A main challenge in the development of new agents for the treatment of Pseudomonas aeruginosa infections is the identification of chemotypes that efficiently penetrate the cell envelope and are not susceptible to established resistance mechanisms. Siderophore-conjugated monocarbams are attractive because of their ability to hijack the bacteria's iron uptake machinery for transport into the periplasm and their inherent stability to metallo-β-lactamases. Through development of the SAR we identified a number of modifications to the scaffold that afforded active anti-P. aeruginosa agents with good physicochemical properties. Through crystallographic efforts we gained a better understanding into how these compounds bind to the target penicillin binding protein PBP3 and factors to consider for future design.


    Organizational Affiliation

    Infection Innovative Medicines, AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Penicillin-binding protein 3
A
538Pseudomonas aeruginosa PA14Mutation(s): 0 
Find proteins for A0A0M3KKZ3 (Pseudomonas aeruginosa PA14)
Go to UniProtKB:  A0A0M3KKZ3
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
3LE
Query on 3LE

Download SDF File 
Download CCD File 
A
(3S,4S,7Z)-7-(2-amino-1,3-thiazol-4-yl)-4-formyl-1-[({3-(5-hydroxy-4-oxo-3,4-dihydropyridin-2-yl)-4-[3-(methylsulfonyl)propyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl}sulfonyl)amino]-3,10,10-trimethyl-1,6-dioxo-9-oxa-2,5,8-triazaundec-7-en-11-oic acid
C25 H32 N10 O13 S3
KOZNTWBICKFGGR-BECCELLYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.99 Å
  • R-Value Free: 0.220 
  • R-Value Work: 0.190 
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 68.442α = 90.00
b = 83.337β = 90.00
c = 89.411γ = 90.00
Software Package:
Software NamePurpose
Cootmodel building
MOLREPphasing
XDSdata reduction
SCALAdata scaling
BUSTERrefinement

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2014-09-10 
  • Released Date: 2015-04-22 
  • Deposition Author(s): Ferguson, A.D.

Revision History 

  • Version 1.0: 2015-04-22
    Type: Initial release
  • Version 1.1: 2015-06-10
    Type: Database references